In the current study of TRD subjects treated with ketamine, and in our prior study of TRD subjects treated with ECT, no relationship between IL-8 change and depressive symptom change would have emerged had we analyzed the data without regard to sex. The gene discussed is CXCL8; the disease is treatment resistant depression.